DRUG · Unmapped registry intervention
Eslicarbazepine acetate (BIA 2-093)
Find medicine records ·
Find other trials using this name
Clinical trial
Eslicarbazepine Acetate as Therapy in Diabetic Neuropathic Pain
NCT01129960
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Unmapped registry intervention
Placebo
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedEslicarbazepine Acetate as Therapy in Diabetic Neuropathic Pain
Design: INTERVENTIONAL · Status: TERMINATED · Phase: PHASE3
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Painful Diabetic Neuropathyunresolved
Interventions
Sponsors & collaborators
Bial - Portela C S.A.lead sponsor
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01129960 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.